biotech primer logo
Keeping Cancer In The Crosshairs

Keeping Cancer In The Crosshairs

by | Jun 26, 2019 | Oncology

Keeping Cancer In The Crosshairs With Targeted Therapies One of the biggest stories in last week’s biotech news headlines was Pfizer’s (New York, NY) acquisition of Array Biopharma (Boulder, CO) for the tidy sum of $11 billion. Array specializes in targeted cancer...